First Databank, Inc.

FDB (First Databank) is a leading provider of drug and medical device databases and clinical decision support solutions, dedicated to helping healthcare professionals make precise medication decisions. The company's mission is to improve patient safety, operational efficiency, and healthcare outcomes by transforming complex drug knowledge into actionable, targeted, and effective solutions. Headquartered in South San Francisco, California, FDB also maintains offices in Indianapolis, Indiana, Exeter, England, Dubai, UAE, and Hyderabad, India.

FDB's core offerings include FDB MedKnowledge, a widely utilized source of drug information in the U.S. and Canada that provides comprehensive clinical data, pricing, and decision support for drug-drug interactions, allergies, and more. Other key products include FDB OrderKnowledge, a drug ordering knowledge base for physicians, and FDB Vela, a cloud-native ePrescribing network designed to streamline prescription information flow and provide real-time benefits verification. Additionally, FDB offers medical device databases to enhance clinical and operational outcomes, and Meducation, which simplifies medication instructions for patients in multiple languages.

In recent developments, FDB appointed David Delaney, MD, as its new President in February 2026, signaling a continued focus on AI-enabled, patient-specific medication intelligence. The company has been actively advancing its FDB MedProof MCP™ Server, an AI integration layer for clinical decision support and workflow automation, with recent announcements in March 2026 regarding its role in agentic integrations. FDB also expanded its FDB Vela network in April 2026 through a collaboration with Photon to enhance cost transparency and patient choice in ePrescribing, and launched RxWallet® on FDB Vela to provide real-time prescription price transparency for consumers.